{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:15:55Z","timestamp":1775553355319,"version":"3.50.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Methods for measuring drug levels in the body are crucial for improving therapeutic drug monitoring (TDM) and personalized medicine. In solid-organ transplants, TDM is essential for the management of immunosuppressive drugs to avoid toxicity and organ rejection. Everolimus is a commonly used immunosuppressant with a small range of safe doses; therefore, it is important to adjust the dose according to each patient's needs. Therefore, reliable methods are required to accurately measure everolimus levels. This study aims to conduct a comprehensive and updated narrative review of chromatographic bioanalytical methods for everolimus quantification.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The authors searched for original research articles published between 2013 and 2023 in Scopus and PubMed and found 295 articles after removing duplicates. Based on their titles and summaries, 30 articles were selected for a detailed review and 25 articles were included in the final analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among the 25 studies, 16 used protein precipitation, mainly with methanol, to prepare the samples, 12 used high-performance liquid chromatography, 11 used ultra-performance liquid chromatography, and 2 used both. Almost all the studies (24 of 25) used tandem mass spectrometry for detection, whereas only 1 used ultraviolet.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This comprehensive review of bioanalytical methods for measuring everolimus using chromatography is a useful resource for researchers developing bioanalytical methods for TDM applications. Future trends in everolimus measurement include achieving lower detection limits, owing to the trend of reducing drug doses in therapy by improving sample extraction techniques and using more sensitive methods.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001273","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T18:01:30Z","timestamp":1729792890000},"page":"49-63","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A Narrative Review of Chromatographic Bioanalytical Methods for Quantifying Everolimus in Therapeutic Drug Monitoring Applications"],"prefix":"10.1097","volume":"47","author":[{"given":"Julia O.","family":"Nascimento","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacometrics (LabFarma), School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edlaine R.","family":"Costa","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacometrics (LabFarma), School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Estrela","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacometrics (LabFarma), School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; and"},{"name":"STD\/AIDS Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Fiocruz, RJ, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda L.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacometrics (LabFarma), School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"R1-20250108","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/bcp.13047","article-title":"Therapeutic drug monitoring in the era of precision medicine: opportunities","volume":"82","author":"Cremers","year":"2016","journal-title":"Br J Clin Pharmacol."},{"key":"R2-20250108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpba.2017.10.039","article-title":"Development and validation of an analytical method using UPLC\u2013MS\/MS to quantify Everolimus in dried blood spots in the oncology setting","volume":"149","author":"Knapen","year":"2018","journal-title":"J Pharm Biomed Anal."},{"key":"R3-20250108","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/dta.2290","article-title":"Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs","volume":"10","author":"Zhang","year":"2018","journal-title":"Drug Test Anal."},{"key":"R4-20250108","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trac.2015.11.016","article-title":"Recent advances in therapeutic drug monitoring of immunosuppressive drugs","volume":"79","author":"Freudenberger","year":"2016","journal-title":"Trac Trends Anal Chem."},{"key":"R5-20250108","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/FTD.0000000000000126","article-title":"Comparison of Everolimus QMS immunoassay on Architect ci4100 and liquid chromatography\/mass spectrometry: lack of agreement in organ-transplanted patients","volume":"37","author":"Hoffer","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R6-20250108","first-page":"1220","article-title":"Everolimus. Novartis","volume":"2","author":"Dumont","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"R8-20250108","doi-asserted-by":"crossref","first-page":"100655","DOI":"10.1016\/j.trre.2021.100655","article-title":"An overview of the efficacy and safety of Everolimus in adult solid organ transplant recipients","volume":"36","author":"Tedesco-Silva","year":"2022","journal-title":"Transpl Rev"},{"key":"R9-20250108","doi-asserted-by":"crossref","first-page":"342","DOI":"10.18632\/oncotarget.28410","article-title":"Cancer prevention with rapamycin","volume":"14","author":"Blagosklonny","year":"2023","journal-title":"Oncotarget"},{"key":"R10-20250108","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/TP.0b013e31820ae4ac","article-title":"CYP3A5 genotype does not influence Everolimus in vitro metabolism and clinical pharmacokinetics in renal transplant recipients","volume":"91","author":"Picard","year":"2011","journal-title":"Transplantation"},{"key":"R11-20250108","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41397-020-0152-7","article-title":"Effect of genetic polymorphisms in CYP3A4, CYP3A5, and m-TOR on Everolimus blood exposure and clinical outcomes in cancer patients","volume":"20","author":"Bonnet","year":"2020","journal-title":"Pharmacogenomics J."},{"key":"R13-20250108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1472-8206.2011.00957.x","article-title":"Sirolimus and Everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus","volume":"26","author":"Lamoureux","year":"2012","journal-title":"Fundam Clin Pharmacol."},{"key":"R14-20250108","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/17425255.4.6.807","article-title":"Everolimus: an update on the mechanism of action, pharmacokinetics and recent clinical trials","volume":"4","author":"S\u00e1nchez-Fructuoso","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol."},{"key":"R15-20250108","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00280-016-3050-6","article-title":"Everolimus pharmacokinetics and its exposure\u2013toxicity relationship in patients with thyroid cancer","volume":"78","author":"De Wit","year":"2016","journal-title":"Cancer Chemother Pharmacol."},{"key":"R16-20250108","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/FTD.0000000000000628","article-title":"Therapeutic drug monitoring of everolimus in oncology: evidences and perspectives","volume":"41","author":"Falkowski","year":"2019","journal-title":"Ther Drug Monit."},{"key":"R17-20250108","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s40267-017-0403-0","article-title":"A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimus","volume":"33","author":"Jacob","year":"2017","journal-title":"Drugs Ther Perspect."},{"key":"R18-20250108","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10637-021-01131-4","article-title":"Real-world pharmacokinetics and pharmacodynamics of everolimus in metastatic breast cancer","volume":"39","author":"Fukudo","year":"2021","journal-title":"Invest New Drugs"},{"key":"R19-20250108","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol."},{"key":"R20-20250108","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1007\/s00216-015-8799-7","article-title":"Possibilities and limitations of signal summing for an immunosuppressant LC-MS\/MS method","volume":"407","author":"Pauwels","year":"2015","journal-title":"Anal Bioanal Chem."},{"key":"R21-20250108","first-page":"27","article-title":"Everolimus method comparison between Waters MassTrak\u2122 Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS\/MS method in renal transplant patients","volume":"45","author":"Johnson-Davis","year":"2015","journal-title":"Ann Clin Lab Sci."},{"key":"R22-20250108","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1039\/c3ay40603b","article-title":"Validation and application of a fast semi-automated whole blood extraction for LC-MS\/MS simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and Everolimus\u2013application to high throughput routine therapeutic drug monitoring","volume":"5","author":"Bouqui\u00e9","year":"2013","journal-title":"Anal Methods"},{"key":"R23-20250108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jmsacl.2021.01.003","article-title":"Validation of a simple liquid chromatography coupled to tandem mass spectrometry method for the simultaneous determination of tacrolimus, sirolimus, Everolimus and cyclosporin A in dried matrix on paper discs","volume":"19","author":"Bress\u00e1n","year":"2021","journal-title":"J Mass Spectrom Adv Clin Lab"},{"key":"R24-20250108","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2019.07.026","article-title":"A high-throughput LC-MS\/MS method for the quantification of four immunosuppressants drugs in whole blood","volume":"498","author":"Gong","year":"2019","journal-title":"Clin Chim Acta"},{"key":"R25-20250108","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/FTD.0000000000000006","article-title":"A direct method for the measurement of Everolimus and sirolimus in whole blood by LC\u2013MS\/MS using an isotopic Everolimus internal standard","volume":"36","author":"Morgan","year":"2014","journal-title":"Ther Drug Monit."},{"key":"R26-20250108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clinbiochem.2019.11.006","article-title":"An isotope dilution LC-MS\/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and Everolimus in human whole blood","volume":"82","author":"Taibon","year":"2020","journal-title":"Clin Biochem."},{"key":"R27-20250108","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1002\/cptx.92","article-title":"Analysis of immunosuppressant drugs in whole blood by liquid chromatography\u2013tandem mass spectrometry (LC-MS\/MS)","volume":"84","author":"Pablo","year":"2020","journal-title":"Curr Protoc Toxicol."},{"key":"R28-20250108","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1515\/cclm-2015-0519","article-title":"Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS\/MS method to determine ciclosporin A, Everolimus, sirolimus and tacrolimus in whole blood","volume":"54","author":"Valbuena","year":"2016","journal-title":"Clin Chem Lab Med."},{"key":"R29-20250108","doi-asserted-by":"crossref","first-page":"121772","DOI":"10.1016\/j.jchromb.2019.121772","article-title":"A new HPLC-MS\/MS method for simultaneous determination of Cyclosporine A, Tacrolimus, Sirolimus and Everolimus for routine therapeutic drug monitoring","volume":"1128","author":"Krn\u00e1\u010d","year":"2019","journal-title":"J Chromatogr B, Anal Tech Biomed Life Sci."},{"key":"R30-20250108","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4155\/bio.14.43","article-title":"A simple and robust LC\u2013MS\/MS method for measuring sirolimus and Everolimus in whole blood","volume":"6","author":"Yuan","year":"2014","journal-title":"Bioanalysis"},{"key":"R31-20250108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2017.12.012","article-title":"Development of a fast HPLC-DAD method for simultaneous quantitation of three immunosuppressant drugs in whole blood samples using intelligent chemometrics resolving of coeluting peaks in the presence of blood interferences","volume":"1073","author":"Vosough","year":"2018","journal-title":"J Chromatogr B, Anal Tech Biomed Life Sci."},{"key":"R32-20250108","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.clinbiochem.2016.06.013","article-title":"Experiences from using LC-MS\/MS for analysis of immunosuppressive drugs in a TDM service","volume":"49","author":"Pohanka","year":"2016","journal-title":"Clin Biochem."},{"key":"R33-20250108","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.clinbiochem.2013.08.013","article-title":"Immunosuppressant therapeutic drug monitoring by LC-MS\/MS: workflow optimization through automated processing of whole blood samples","volume":"46","author":"Marinova","year":"2013","journal-title":"Clin Biochem."},{"key":"R34-20250108","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.3390\/molecules27134087","article-title":"Simultaneous determination of six immunosuppressants in human whole blood by HPLC-MS\/MS using a modified QuEChERS method","volume":"27","author":"Zheng","year":"2022","journal-title":"Molecules"},{"key":"R35-20250108","doi-asserted-by":"crossref","first-page":"e5071","DOI":"10.1002\/bmc.5071","article-title":"Simultaneous quantification of cyclosporin, tacrolimus, sirolimus and Everolimus in whole blood by UHPLC\u2013MS\/MS for therapeutic drug monitoring","volume":"35","author":"Antunes","year":"2021","journal-title":"Biomed Chromatogr."},{"key":"R36-20250108","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jchromb.2013.03.014","article-title":"Two rapid ultra performance liquid chromatography\/tandem mass spectrometry (UPLC\/MS\/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay","volume":"928","author":"Tszyrsznic","year":"2013","journal-title":"J Chromatogr B, Anal Tech Biomed Life Sci."},{"key":"R37-20250108","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchromb.2018.11.030","article-title":"Validation and clinical application of an LC-MS\/MS method for the quantification of Everolimus using volumetric absorptive microsampling","volume":"1104","author":"Verheijen","year":"2019","journal-title":"J Chromatogr B, Anal Tech Biomed Life Sci."},{"key":"R38-20250108","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4155\/bio-2016-0296","article-title":"Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC\u2013MS\/MS systems","volume":"9","author":"Koster","year":"2017","journal-title":"Bioanalysis"},{"key":"R39-20250108","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/bio-2018-0312","article-title":"A volumetric absorptive microsampling LC\u2013MS\/MS method for five immunosuppressants and their hematocrit effects","volume":"11","author":"Koster","year":"2019","journal-title":"Bioanalysis"},{"key":"R40-20250108","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4155\/bio-2018-0227","article-title":"HPLC\u2013MS\/MS-based analysis of Everolimus in rabbit aqueous humor: pharmacokinetics of in situ gel eye drops of suspension","volume":"11","author":"Tang","year":"2019","journal-title":"Bioanalysis"},{"key":"R41-20250108","doi-asserted-by":"crossref","first-page":"113644","DOI":"10.1016\/j.jpba.2020.113644","article-title":"Development and validation of a simple and versatile method for the quantification of Everolimus loaded in H-ferritin nanocages using UHPLC-MS\/MS","volume":"191","author":"Sottani","year":"2020","journal-title":"J Pharm Biomed Anal."},{"key":"R42-20250108","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.4155\/bio-2019-0143","article-title":"A multidrug LC\u2013MS\/MS method for the determination of five immunosuppressants in oral fluid","volume":"11","author":"Paniagua-Gonz\u00e1lez","year":"2019","journal-title":"Bioanalysis"},{"key":"R43-20250108","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jms.3909","article-title":"First UHPLC\u2013MS\/MS method coupled with automated online SPE for quantification both of tacrolimus and Everolimus in peripheral blood mononuclear cells and its application on samples from co-treated pediatric patients","volume":"52","author":"Pensi","year":"2017","journal-title":"J Mass Spectrom."},{"key":"R44-20250108","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.3390\/molecules25174026","article-title":"Review of chromatographic methods coupled with modern detection techniques applied in the therapeutic drugs monitoring (TDM)","volume":"25","author":"Tuzimski","year":"2020","journal-title":"Molecules"},{"key":"R45-20250108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jmsacl.2022.06.002","article-title":"Clinical validation of a liquid chromatography-tandem mass spectrometry method for the quantification of calcineurin and mTOR inhibitors in dried matrix on paper discs","volume":"25","author":"Bress\u00e1n","year":"2022","journal-title":"J Mass Spectrom Adv Clin Lab."},{"key":"R46-20250108","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1021\/ac5022562","article-title":"Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis","volume":"86","author":"Denniff","year":"2014","journal-title":"Anal Chem."},{"key":"R48-20250108","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/FTD.0000000000000260","article-title":"Therapeutic drug monitoring of everolimus: a consensus report","volume":"38","author":"Shipkova","year":"2016","journal-title":"Ther Drug Monit."},{"key":"R49-20250108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/cclm-2022-0699","article-title":"Evaluation of the interchangeability between the new fully-automated affinity chrome-mediated immunoassay (ACMIA) and the Quantitative Microsphere System (QMS) with a CE-IVD-certified LC-MS\/MS assay for therapeutic drug monitoring of everolimus after solid organ transplantation","volume":"61","author":"Ialongo","year":"2022","journal-title":"Clin Chem Lab Med."},{"key":"R50-20250108","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/rcm.7887","article-title":"Immunosuppressive drugs in whole blood: validation of a commercially available liquid chromatography\/tandem mass spectrometry kit and comparison with immunochemical assays","volume":"31","author":"Polledri","year":"2017","journal-title":"Rapid Commun Mass Spectrom."},{"key":"R51-20250108","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clinbiochem.2010.10.005","article-title":"Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS\/MS, HPLC-UV and immunoassay methods","volume":"44","author":"Sallustio","year":"2011","journal-title":"Clin Biochem."},{"key":"R52-20250108","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1515\/cclm-2020-0848","article-title":"Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS\/MS-based clinical analyzer suggests a new era in laboratory medicine","volume":"59","author":"H\u00f6rber","year":"2021","journal-title":"Clin Chem Lab Med."},{"key":"R53-20250108","first-page":"300","article-title":"Avalia\u00e7\u00e3o de aditivos de fase m\u00f3vel e temperatura na vida \u00fatil de colunas para cromatografia l\u00edquida de alta efici\u00eancia","volume":"43","author":"Gomes","year":"2020","journal-title":"Qu\u00edmica Nova"},{"key":"R54-20250108","article-title":"Desenvolvimento de m\u00e9todos cromatogr\u00e1ficos para a determina\u00e7\u00e3o simult\u00e2nea, em plasma humano, de f\u00e1rmacos usados no tratamento de doen\u00e7as cardiovasculares [MSc thesis]","author":"Souza"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:00:47Z","timestamp":1736348447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001273","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"2024-07-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}